Palladio Group presents intelligent packaging for the pharmaceutical sector

Intelligent packaging that supports patients in their drug therapy. With this aim in mind, the Palladio Group has developed ‚PluggyMed‘ blister packaging.

As an exhibitor at CPhI Worldwide in Milan, the Palladio Group presented its new innovation programme ‚PhutureMed‘ in November. The Italian supplier of pharmaceutical packaging is focussing on topics such as intelligent packaging, clinical tests, traceability and anti-counterfeiting.

One Intelligent packaging, that supports patients in monitoring and adhering to their drug therapy. With this in mind, the Palladio Group, a company in the packaging sector, has developed the PluggyMed‚ blister pack‘ developed. The Italian group presented the new product at the CPhI Worldwide in Milan and announced her PhutureMed‚ technological innovation programme‘ with which it will go in search of new impulses for innovative solutions for the medicine of the future.

Linking through conductive ink

„PluggyMed is a system that can be used in Cooperation with the software company Omnys was developed in Vicenza. Thanks to the Printing conductive inks enables the interaction between the blister packaging and the of the drug and an intelligent device, to monitor the patient's adherence to treatment. The information collected is then shared in a cloud platform that can be accessed not only by the patient themselves via smartphone, but also by various carers such as the family doctor or family members.“

Gabriele Molari, Head of Marketing & Customer Innovation at the Palladio Group and coordinator of the ‚PhutureMed‘ programme

Display

The product is intended to Simplify compliance with drug therapyBy downloading the smartphone application, patients can view and check the treatment programme and receive notifications reminding them to take their medication correctly. The data collected by the app thus enables constant monitoring of the therapy programme and creates a Database with useful information not only for doctors, but also for pharmaceutical companies.

Palladio favours innovation through exchange

„This solution,“ says Antonio Marchi, Chief Strategy Officer of the Palladio Group, is a prototype that was developed as part of the „PhutureMed‚ innovation programme. It is the first in a series of programmes with which the Palladio Group is developing a truly open innovation centre for pharmaceuticals and manage a company that not only involves customers and suppliers, but also employees, universities, start-ups and research centres in research and development. innovative solutions to meet the changes in the pharmaceutical world. “The ‚PhutureMed‘ programme is new and reflects the Palladio Group's goal of creating new synergies to meet the needs of the market.“

„At the Milan trade fair, in line with this open innovation approach, we were able to present other concepts that are still in development and address current issues in the pharmaceutical sector, such as the Remote management of clinical tests, anti-counterfeiting and traceability. In this way, we have openly shared our ideas and started an exchange with the trade fair visitors to better understand their needs, adapt concepts and develop solutions together.“

Gabriele Molari

Fingerprint to prevent counterfeiting

The Palladio Group presented a concept in Milan that aims to quickly solve the problem of discrepancies in some information about a drug undergoing clinical trials. „It is a solution that works with electronic ink (E-Ink) works„, says Molari, „which makes it possible to change information directly on the pharmaceutical packaging remotely, and only by people who are authorised to do so“.

The manager summarises: „To always more secure and customised services in the area of anti-counterfeiting and product traceability we also presented studies at the trade fair that we have developed with a number of partners. The idea is based on the concept of a „fingerprint“, which contains a unique code that is printed on the pharmaceutical packaging. will. The classic QR or data matrix codes are easier to counterfeit, which is why we suggest using an image, such as a logo, that always looks the same to the human eye, but which actually contains a unique code that can be scanned with a special smartphone app. In this way, the patient can also check whether it is an original product and receive increasingly personalised information.“

palladiogroup.com

More news